Neumora Therapeutics, Inc. (NMRA)

2.64 -0.19 (-6.71%) USD  |  NASDAQ  |  Mar 18, 16:00
2.635 0.00 (0.00%) After-Hours: 20:00
More

Neumora Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for NMRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Nautilus Biotechnology, Inc. Upgrade
Ventyx Biosciences, Inc. (DELISTED) Upgrade
ProKidney Corp. --